A detailed history of King Luther Capital Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, King Luther Capital Management Corp holds 133,682 shares of LLY stock, worth $106 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
133,682
Previous 129,181 3.48%
Holding current value
$106 Million
Previous $117 Million 1.26%
% of portfolio
0.52%
Previous 0.53%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $3.48 Million - $4.32 Million
4,501 Added 3.48%
133,682 $118 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $1.74 Million - $2.18 Million
2,397 Added 1.89%
129,181 $117 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $7.51 Million - $10 Million
12,677 Added 11.11%
126,784 $98.6 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $15.5 Million - $18.2 Million
29,443 Added 34.78%
114,107 $66.5 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $16.9 Million - $23.4 Million
38,970 Added 85.28%
84,664 $45.5 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $5.53 Million - $7.4 Million
15,772 Added 52.71%
45,694 $21.4 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $342,314 - $402,031
1,102 Added 3.82%
29,922 $10.3 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $961,434 - $1.12 Million
2,990 Added 11.58%
28,820 $10.5 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $299,148 - $340,910
-1,009 Reduced 3.76%
25,830 $8.35 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $437,327 - $513,486
1,569 Added 6.21%
26,839 $8.7 Million
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $27,458 - $34,124
-117 Reduced 0.46%
25,270 $7.24 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $190,897 - $236,904
849 Added 3.46%
25,387 $7.01 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $91,520 - $112,629
-413 Reduced 1.66%
24,538 $5.67 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $1.45 Million - $1.88 Million
-8,058 Reduced 24.41%
24,951 $5.73 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $18,075 - $23,399
-110 Reduced 0.33%
33,009 $6.17 Million
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $134,634 - $178,154
-1,032 Reduced 3.02%
33,119 $5.59 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $1,754 - $2,029
12 Added 0.04%
34,151 $5.06 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $79,805 - $96,045
-585 Reduced 1.68%
34,139 $5.61 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $285,243 - $353,050
-2,396 Reduced 6.45%
34,724 $4.82 Million
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $111,731 - $138,389
1,045 Added 2.9%
37,120 $4.88 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $109,139 - $118,715
-1,022 Reduced 2.75%
36,075 $4.03 Million
Q2 2019

Aug 12, 2019

BUY
$110.79 - $129.32 $17,726 - $20,691
160 Added 0.43%
37,097 $4.11 Million
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $223,955 - $263,612
-2,012 Reduced 5.17%
36,937 $4.79 Million
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $72,329 - $81,031
683 Added 1.78%
38,949 $4.51 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $19,833 - $24,788
231 Added 0.61%
38,266 $4.11 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $18,395 - $21,111
-243 Reduced 0.63%
38,035 $3.25 Million
Q1 2018

May 08, 2018

SELL
$74.21 - $87.6 $37,476 - $44,238
-505 Reduced 1.3%
38,278 $2.96 Million
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $125,286 - $134,383
1,529 Added 4.1%
38,783 $3.28 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $2.87 Million - $3.19 Million
37,254
37,254 $3.19 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.